Results 161 to 170 of about 190,539 (312)

FLOT1 Is a Novel Serum Biomarker of Ovarian Cancer Targeted by N6‐methyladenosine Modification Inhibition

open access: yesCell Biology International, EarlyView.
ABSTRACT Ovarian cancer (OC) is a deadly disease and lacks a precise marker for diagnosis worldwide. Our previous work has shown the overexpression of flotillin‐1 (FLOT1) in OC tissue. To improve diagnostic sensitivity and accuracy, we evaluated the serum level of FLOT1 in OC patients and found that the serum concentration of FLOT1 as well as CA125 was
Bin Guan   +7 more
wiley   +1 more source

Value of Renal Blood Flow Measurement with Xenon-133 at the Time of Kidney Transplantation

open access: green, 1967
David H. Lewis   +5 more
openalex   +2 more sources

Transplantation Antibody Associated with First-Set Renal Homografts [PDF]

open access: bronze, 1968
Frederick W. Spong   +2 more
openalex   +1 more source

The International TrifectaTM and EpicTM Valve‐in‐Valve Registry: Insights Into Clinical & Hemodynamic Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler   +9 more
wiley   +1 more source

Toxic effects of heavy metal exposure in solid organ transplant recipients

open access: yesTransplantation Reports
Heavy metal toxicity has recently been described in solid organ transplant recipients. Allograft dysfunction or failure associated with arsenic, cadmium, chromium, cobalt and lead exposure have been reported, largely in renal transplant recipients, but ...
Daniel Glicklich   +2 more
doaj  

Home - About - Disclaimer - Privacy